Cisplatin- and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice

Fundamental and Clinical Pharmacology

Volumn 27, Issue 3, 2013, Pages 329-338

  Martha, Kham R M ^a   Rosangkima, Gabriel ^a   Amenla, Longchar ^a   Rongpi, Thengtom ^a   Prasad, Surya B ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Ascorbic acid; Cisplatin; Dalton's lymphoma; Mitochondria

Indexed keywords

ASCORBIC ACID; CISPLATIN; MITOCHONDRIAL PROTEIN; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; CANCER GROWTH; CANCER TRANSPLANTATION; CELL VACUOLE; CONTROLLED STUDY; DALTON LYMPHOMA; ENZYME ACTIVITY; IN VIVO STUDY; KIDNEY MITOCHONDRION; LIPID PEROXIDATION; LIVER MITOCHONDRION; LYMPHOMA; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SINGLE DRUG DOSE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCITES; ASCORBIC ACID; CISPLATIN; DRUG THERAPY, COMBINATION; KIDNEY; LIPID PEROXIDATION; LYMPHOMA; MALE; MICE; MITOCHONDRIA; MITOCHONDRIA, LIVER; NEOPLASMS, EXPERIMENTAL; TIME FACTORS;

EID: 84877802444     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2011.01019.x     Document Type: Article

References (68)

1. Yang Z., Schumaker L.M., Egorin M.J., Zuhowski E.G., Guo Z., Cullen K.J.Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin. Cancer Res. (2006) 12 5817-5825.
2. Go R.S., Adjei A.A.Review of comparative pharmacology and clinical activity of cisplatin and carboplatin. J. Clin. Oncol. (1999) 17 409-422.
3. Yao X., Panichpisal K., Neilkurtzman N., Nugent K.Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. (2007) 334 115-124.
4. P450 2E1. Toxicol. Sci. (2006) 89 515-523.
5. Prasad S.B., Khynriam D.Mutagenicity and endogenous glutathione levels in tumor-bearing mice after cisplatin treatment, in: Khassanova L., Collery P., Maymard I., Khassanova Z., Etienne J.C. (Eds), Metal Ions in biology and medicine. Vol 7, John Libbey Eurotext, Paris, France, 2002, pp. 580-585.
6. Kartalou M., Essigmann J.M.Mechanisms of resistance to cisplatin. Mutat. Res. (2001) 478 23-48.
7. Eastman A.Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cell (1990) 2 275-280.
8. Eastman A., Barry M.A.The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis?Cancer Invest. (1992) 10 229-240.
9. Siddik Z.H.Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene (2003) 22 7265-7279.
10. Fuertes M.A., Alonso C., Perez M.Biochemical modulation of cisplatin mechanisms of action : enhancement of antitumor activity and circumvention of drug resistance. Chem. Rev. (2003) 103 645-662.
11. Cullen K.J., Yang Z., Schumaker L., Guo Z.Mitochondria as a critical target of the chemotherapeutic agent cisplatin in head and neck cancer. J. Bioenerg. Biomembr. (2007) 39 43-50.
12. Fuertes M.A., Castilla J., Alonso C., Perez J.M.Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr. Med. Chem. (2003) 10 257-266.
13. Gonzalez V.M., Fuertes M.A., Alonso C., Perez J.M.Is cisplatin-induced cell death always produced by apoptosis?Mol. Pharmacol. (2001) 59 657-663.
14. Olivero O.A., Chang P.K., Lopez-Larraza D.M., Semino-Mora M.C., Poirrier M.C.Preferential formation and decreased removal of cisplatin DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutat. Res. (1997) 391 79-86.
15. Prasad S.B., Giri A., Khynriam D., Kharbangar A., Nicol B.M., Lotha C.Cisplatin-mediated enzymatic changes in mice bearing ascites Dalton's lymphoma. Med. Sci. Res. (1999) 27 723-730.
16. Murphy M.P., Smith R.A.J.Drug delivery to mitochondria: the key to mitochondrial medicine. Adv. Drug Deliv. Rev. (2000) 41 235-250.
17. Petit P.X., Le Cover H., Zorn H., Dauget C., Mignotte B., Gougeon M.L.Alteration of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. (1995) 130 156-167.
18. Souid A.K., Tacka K.A., Galvan K.A., Penefsky H.S.Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem. Pharmacol. (2003) 66 977-987.
19. Schwerdt G., Freudinger R., Schuster C., Weber F., Thews O., Gekle M.CIsplatin-induced apoptosis is enhanced by hypoxia and by inhibition of mitochondria in renal collecting duct cells. Toxicol. Sci. (2005) 85 735-742.
20. Kruidering M., Van de Water B., de Heer E., Mulder G.J., Nagelkerke J.F.Cisplatin-induced nephrotoxicity in porcine proximal tubule cells: mitochondrial dysfunction by inhibition of complex I to IV of the respiratory chain. J. Pharmacol. Exp. Ther. (1997) 280 638-649.
21. Martins N.M., Santos N.A.G., Curti C., Bianchi M.L.P., Santos A.C.Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Toxicol. (2007) 28 337-344.
22. Ilbey Y.O., Ozbek E., Cekmen M., Simsek A., Otunctemur A., Somay A.Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum. Reprod. (2009) 24 1717-1725.
23. Custodio J.B., Cardoso C.M., Santos M.S., Almeida L.M., Vicente J.A., Fernandes M.A.Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents. Toxicology (2009) 259 18-24.
24. Beltrame M., Sindellari L., Arslan P.Effects of newly synthesized platinum (II) complexes on mitochondrial functions. Chem. Biol. Interact. (1984) 50 247-254.
25. Park M.S., De Leon M., Devarajan P.Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J. Am. Soc. Nephrol. (2002) 13 858-865.
26. Saeed R.W., Peng T., Metz C.N.Ascorbic acid blocks the growth inhibitory effect of tumor necrosis factor-alpha on endothelial cells. Exp. Biol. Med. (2003) 228 855-865.
27. Rossig L., Hoffmann J., Hugel B. et al.Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation (2001) 104 2182-2187.
28. Dhar-Mascareno M., Carcamo J.M., Golde D.W.Hypoxia-reoxygenation-induced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. Free Radic. Biol. Med. (2005) 38 1311-1322.
29. Huang J., May J.M.Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Brain Res. (2006) 1097 52-58.
30. Kang Y.H., Park S.H., Lee Y.J. et al.Antioxidant alpha-ketocarboxylate pyruvate protects low-density lipoprotein and atherogenic macrophages. Free Radic. Res. (2002) 36 905-914.
31. Loke W.M., Proudfoot J.M., McKinley A.J., Croft K.D.Augmentation of monocyte intracellular ascorbate in vitro protects cells from oxidative damage and inflammatory responses. Biochem. Biophys. Res. Commun. (2006) 345 1039-1043.
32. Giri A., Khianriam D., Prasad S.B.Vitamin C mediated protection against cisplatin induced mutagenicity in mice. Mutat. Res. (1998) 421 139-148.
33. Wenzel W., Nickel A., Kuntz S., Daniel H.Ascorbic suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Carcinogenesis (2004) 25 703-712.
34. Sestili P., Brandi G., Brambilla L., Cattabeni F., Cantoni O.Hydrogen peroxide mediates the killing of U937 tumor cells elicited by pharmacologically attainable concentrations of ascorbic acid: cell death prevention by extracellular catalase from cocultured erythrocytes or fibroblasts. J. Pharmacol. Exp. Ther. (1996) 277 1719-1725.
35. Chen Q., Espey M.G., Krishna M.C. et al.Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc. Natl Acad. Sci. USA (2005) 102 13604-13609.
36. Kassouf W., Highshaw R., Nelkin G.M., Dinney C.P., Kamat A.M.Vitamins C and K3 sensitize human urothelial tumors to gemcitabine. J. Urol. (2006) 176 1642-1647.
37. Grad J.M., Bahlis N.J., Reis I., Oshiro M.M., Dalton W.S., Boise L.H.Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood (2001) 98 805-813.
38. Abdel-Latif M.M., Raouf A.A., Sabra K., Kelleher D., Reynolds J.V.Vitamin C enhances chemosensitization of esophageal cancer cells in vitro. J. Chemother. (2005) 17 539-549.
39. Verrax J., Stockis J., Tison A., Taper H.S., Calderon P.B.Oxidative stress by ascorbate/menadione association kills K562 human chronic myelogenous leukaemia cells and inhibits its tumour growth in nude mice. Biochem. Pharmacol. (2006) 72 671-680.
40. Taper H.S., Jamison J.M., Gilloteaux J., Summers J.L., Calderon P.B.Inhibition of the development of metastases by dietary vitamin C:K3 combination. Life Sci. (2004) 75 955-967.
41. Kathi Head N.D.Ascorbic acid in the prevention and treatment of cancer. Altern. Med. Rev. (1998) 3 174-186.
42. Rosenberg B.Fundamental studies with cisplatin. Cancer (1985) 55 2303-2316.
43. Prasad S.B., Rosangkima G., Kharbangar A.Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice. Mitochondrion (2010) 10 38-45.
44. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J.Protein measurement with the Folin phenol reagent. J. Biol. Chem. (1951) 193 265-275.
45. King T.E.Preparation of succinate dehydrogenase and reconstitution of succinate oxidase, in: Estabrook R.W., Pullman M.E. (Eds), Methods in enzymology. Vol X, Academic Press, New York, 1967, pp. 322-331.
46. Buege J.A., Aust S.D.Mirosomal lipid peroxidation. Methods Enzymol. (1978) 52 302-310.
47. Nagy B., Mucsi I., Molnar J., Varga A., Thurzo L.Chemosensitizing effect of vitamin C in combination with 5-fluorouracil in vitro. In Vivo. (2003) 17 289-292.
48. Mikino Y., Sakagami H., Takeda M.Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines. Anticancer Res. (1999) 19 3125-3132.
49. Hanck A.B.Vitamin C and cancer. Prog. Clin. Biol. Res. (1988) 259 307-320.
50. 2+signalling and apoptosis. J. Bioenerg. Biomembr. (2000) 32 35-46.
51. Rosenberg J.M., Sato P.H.Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex. Mol. Pharmacol. (1993) 43 491-497.
52. Heminger K.A., Hartson S.D., Rogers J., Matts R.L.Cisplatin inhibits protein synthesis in rabbit reticulocyte lysate by causing an arrest in elongation. Arch. Biochem. Biophys. (1997) 344 200-207.
53. King M.E., Godman G.C., King D.W.Respiratory enzymes and mitochondrial morphology of HeLa cells treated with chloramphenicol and ethidium bromide. J. Cell Biol. (1972) 53 127-142.
54. White M.T., Ayra D.V., Tewari K.K.Biochemical properties of neoplastic cell mitochondria. J. Natl Cancer Inst. (1974) 53 553-559.
55. Melendez-Zajgla J., Cruz E., Maldonado V., Espinoza A.N.Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin. Biochem. Mol. Biol. Int. (1999) 47 765-771.
56. Brady H.R., Kone B.C., Stromski M.E., Zeidel M.L., Giebisch G., Gullans S.R.Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am. J. Physiol. (1990) 258 1181-1187.
57. Lemarie A., Huc L., Pazarentzos E., Mahul-Mellier A.L., Grimm S.Specific disintegration of complex II succinate:ubiquinoneoxidoreductase links pH changes to oxidative stress for apoptosis induction. Cell Death Differ. (2011) 18 338-349.
58. Bourgeron T., Rustin P., Chretien D. et al.Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat. Genet. (1995) 11 144-149.
59. Kusao I., Troelstrup D., Shiramizu B.Possible mitochondria-associated enzymatic role in non-Hodgkin lymphoma residual disease. Cancer Growth Metastasis (2008) 1 3-8.
60. Pamplona R., Prat J., Cadenas S. et al.Low fatty acid unsaturation protects against lipid peroxidation in liver mitochondria from long-lived species, the pigeon and human case. Mech. Aging Dev. (1996) 86 53-66.
61. Vladimirov Y.A., Olenev V.I., Suslova T.B., Cheremisina Z.P.Lipid peroxidation in mitochondrial membrane. Adv. Lipid Res. (1980) 17 173-249.
62. Szatrowski T.P., Nathan C.F.Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. (1991) 51 794-798.
63. Green D.R., Reed J.C.Mitochondria and apoptosis. Science (1998) 281 1309-1312.
64. Kim J.S., He L., Lemasters J.J.Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. (2003) 304 463-470.
65. Kroemer G., Reed J.C.Mitochondrial control of cell death. Nat. Med. (2000) 6 513-519.
66. Pessayre D., Mansouri A., Haouzi D., Fromenty B.Hepatotoxicity due to mitochondrial dysfunction. Cell Biol. Toxicol. (1999) 15 367-373.
67. Devarajan P., Savoca M., Castaneda M.P. et al.Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hear. Res. (2002) 174 45-54.
68. Yanez J.A., Teng S.W., Roupe K.A., Fariss M.W., Davies N.M.Chemotherapy induced gastrointestinal toxicity in rats: involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J. Pharm. Pharm. Sci. (2003) 6 308-314.